 Home > Medical News > Latest Medical News > WuXi Biologics major shareholder reduces holdings and cashes in by nearly HK$11.6 billion

WuXi Biologics major shareholder reduces holdings and cashes in by nearly HK$11.6 billion

 Last Update: 2021-07-01
 Source: Internet
 Author: User

Tags

iqe share price

wuxi biologics

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On the 27th, WuXi Biologics announced that its major shareholder WuXi Biologics Holdings Limited has entered into a block trading agreement with the placing agent Morgan Stanley to place 108 million existing shares, equivalent to approximately 2.
56% of the issued share capital
.

The allotment price per share was 107 Hong Kong dollars, and the cash was 11.

If the placement is completed as expected, Biologics Holdings’ shareholding ratio will be reduced from 20% to approximately 17.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.